105
Views
21
CrossRef citations to date
0
Altmetric
Original Article

Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab

, , , , , , , , , , , , , & show all
Pages 122-127 | Received 09 Feb 2011, Accepted 03 Jun 2011, Published online: 02 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Özgül Muştu Koryürek & Göknur Kalkan. (2016) A new alternative therapy in dermatology: tocilizumab. Cutaneous and Ocular Toxicology 35:2, pages 145-152.
Read now

Articles from other publishers (19)

Ahnika Kline & Christa Zerbe. 2022. Allergic and Immunologic Diseases. Allergic and Immunologic Diseases 747 790 .
Carla M. Roman‐Montes, Areli Martinez‐Gamboa, Paulette Diaz‐Lomelí, Axel Cervantes‐Sanchez, Andrea Rangel‐Cordero, Jose Sifuentes‐Osornio, Alfredo Ponce‐de‐Leon & Maria F. Gonzalez‐Lara. (2021) Accuracy of galactomannan testing on tracheal aspirates in COVID‐19‐associated pulmonary aspergillosis. Mycoses 64:4, pages 364-371.
Crossref
Celeste Witting, Jessica Quaggin-Smith, Ruben Mylvaganam, Graham Peigh, Michael Angarone & James D. Flaherty. (2021) Invasive pulmonary aspergillosis after treatment with tocilizumab in a patient with COVID-19 ARDS: a case report. Diagnostic Microbiology and Infectious Disease 99:4, pages 115272.
Crossref
Sophie L. Penman, Robyn T. Kiy, Rebecca L. Jensen, Christopher Beoku‐Betts, Ana Alfirevic, David Back, Saye H. Khoo, Andrew Owen, Munir Pirmohamed, B. Kevin Park, Xiaoli Meng, Christopher E. Goldring & Amy E. Chadwick. (2020) Safety perspectives on presently considered drugs for the treatment of COVID‐19. British Journal of Pharmacology 177:19, pages 4353-4374.
Crossref
Xin Li, Susanna KP Lau & Patrick CY Woo. (2020) Fungal infection risks associated with the use of cytokine antagonists and immune checkpoint inhibitors. Experimental Biology and Medicine 245:13, pages 1104-1114.
Crossref
Francisco Javier Candel, Marina Peñuelas, Carolina Tabares, Carolina Garcia-Vidal, Mayra Matesanz, Miguel Salavert, Pilar Rivas & Javier Pemán. (2020) Fungal infections following treatment with monoclonal antibodies and other immunomodulatory therapies. Revista Iberoamericana de Micología 37:1, pages 5-16.
Crossref
Shiang-Fen Huang, Ming-Han Chen, Fu-Der Wang, Chang-Youh Tsai, Chang-Phone Fung & Wei-Juin Su. (2018) Efficacy of isoniazid salvage therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders – A retrospective cohort study in Taiwan. Journal of Microbiology, Immunology and Infection 51:6, pages 784-793.
Crossref
Hiroaki Nishioka, Hiroshi Takegawa & Hiroki Kamei. (2018) Disseminated cryptococcosis in a patient taking tocilizumab for Castleman's disease. Journal of Infection and Chemotherapy 24:2, pages 138-141.
Crossref
Ioannis Kyriakidis, Athanasios Tragiannidis, Ilse Zündorf & Andreas H. Groll. (2017) Invasive fungal infections in paediatric patients treated with macromolecular immunomodulators other than tumour necrosis alpha inhibitors. Mycoses 60:8, pages 493-507.
Crossref
M. Yéléhé-Okouma, J. Henry, N. Petitpain, J.-L. Schmutz & P. Gillet. (2017) Érysipèle sans fièvre ni syndrome inflammatoire lors d’un traitement par tocilizumab. Annales de Dermatologie et de Vénéréologie 144:6-7, pages 434-437.
Crossref
MINSOO CHO, INSUK SO, JUNG NYEO CHUN & JU-HONG JEON. (2016) The antitumor effects of geraniol: Modulation of cancer hallmark pathways (Review). International Journal of Oncology 48:5, pages 1772-1782.
Crossref
Snigdha Vallabhaneni & Tom M. Chiller. (2016) Fungal Infections and New Biologic Therapies. Current Rheumatology Reports 18:5.
Crossref
Fabrizio Cantini, Laura Niccoli, Carlotta Nannini, Emanuele Cassarà, Olga Kaloudi, Ennio Giulio Favalli, Andrea Becciolini, Martina Biggioggero, Maurizio Benucci, Francesca Li Gobbi, Valentina Grossi, Maria Infantino, Francesca Meacci, Mariangela Manfredi, Serena Guiducci, Silvia Bellando-Randone, Marco Matucci-Cerinic, Rosario Foti, Marcella Di Gangi, Marta Mosca, Chiara Tani, Fabrizio Palmieri & Delia Goletti. (2016) Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis. Seminars in Arthritis and Rheumatism 45:5, pages 519-532.
Crossref
Audrey Lasry, Adar Zinger & Yinon Ben-Neriah. (2016) Inflammatory networks underlying colorectal cancer. Nature Immunology 17:3, pages 230-240.
Crossref
John E. McKinnon & Kathleen Maksimowicz-McKinnon. (2016) Autoimmune disease and vaccination: impact on infectious disease prevention and a look at future applications. Translational Research 167:1, pages 46-60.
Crossref
Noboru Takayanagi,. (2015) Biological agents and respiratory infections: Causative mechanisms and practice management. Respiratory Investigation 53:5, pages 185-200.
Crossref
Yoshiyuki Arinuma, Shinichi Nogi, Yuichi Ishikawa, Hisanori Nakayama, Atsushi Hashimoto, Akiko Komiya, Kenji Minoguchi, Ayako Horita, Ikuo Saito, Toshihiro Matsui & Shigeto Tohma. (2015) Fatal Complication of <i>Legionella pneumophila</i> Pneumonia in a Tocilizumab-treated Rheumatoid Arthritis Patient. Internal Medicine 54:9, pages 1125-1130.
Crossref
Sohita Dhillon. (2013) Intravenous Tocilizumab: A Review of Its Use in Adults with Rheumatoid Arthritis. BioDrugs 28:1, pages 75-106.
Crossref
Brian A. Baldo. 2014. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 561 590 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.